NCT07789106 · ClinicalTrials.gov record · last posted 2026-08-27
A Study on Ubiquinol on Fatigue and Muscle Strength in Healthy Adults Taking GLP-1 Agonists
Study acronym: Project Zest
StatusNot Yet Recruiting
PhaseNot applicable
Started2026-09-01
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The goal of this clinical trial is to learn if a daily ubiquinol supplement can reduce fatigue and help maintain muscle strength in adults aged 30-65 who are taking a GLP-1 weight loss medication (Wegovy® or Mounjaro®). Ubiquinol is a form of Coenzyme Q10 (CoQ10), a substance the body makes naturally that plays a key role in energy production. The main questions it aims to answer are:
Does ubiquinol lower fatigue levels compared to a placebo (a look-alike capsule that contains no ubiquinol)? Does ubiquinol help maintain muscle strength during weight loss treatment?
Researchers will compare ubiquinol to a placebo to see if ubiquinol helps with fatigue and muscle strength in people using GLP-1 medications.
Participants will:
Take one ubiquinol (100 mg) or placebo capsule every day for 9 months Have a nurse visit their home 4 times (at months 0, 3, 6, and 9) to take a small blood sample, measure their body, and supervise a simple sit-to-stand exercise test Attend a short monthly video call (about 20-30 minutes) with a study dietitian Complete questionnaires and 4 days of diet logging every 3 months using a smartphone app Log all exercise sessions in the smartphone app throughout the study
This is a fully remote study - participants do not need to visit a clinic. About 90 people will take part.
| NCT Number |
NCT07789106 |
| Lead Sponsor |
StudySetGo
|
| Conditions |
Obesity & Overweight, GLP - 1, Fatigue Severity Scale, Ubiquinol, Muscle Contraction |
| Enrollment |
90 participants |
| Start Date |
2026-09-01 |
| Primary Completion |
2027-12-01 (estimated) |
| Study Completion |
2028-09-01 (estimated) |
| Updated on ClinicalTrials.gov |
2026-08-27 |